KAYLA MERRITT: Open Payments
NPI 1770986697 · JACKSON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,917 in 94 payments from 21 companies in 2025. Trend: 2023 $1,908 · 2024 $2,088 · 2025 $1,917
Food & beverage: $1,917
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $365 |
| Amgen Inc. | 18 | $231 |
| Insulet Corporation | 7 | $169 |
| Lilly USA, LLC | 10 | $139 |
| Novartis Pharmaceuticals Corporation | 8 | $136 |
| Tandem Diabetes Care, Inc. | 4 | $103 |
| Corcept Therapeutics | 5 | $100 |
| Madrigal Pharmaceuticals | 4 | $100 |
| CeQur Corporation | 1 | $98 |
| SANOFI-AVENTIS U.S. LLC | 4 | $87 |
Products named: Ozempic, TEPEZZA, Omnipod, LEQVIO, t:slim X2 Insulin Pump with Control-IQ, Korlym, REZDIFFRA, CeQur Simplicity.
Industry payments across GA — which companies pay providers there.
